VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Vericel Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$40.37+0.24 (+0.60%)
Close on Oct 19, 2026
- Market cap
- $2.11B
- P/E (TTM)
- 96.1
- Dividend yield
- –
Vericel statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Vericel | Industry median |
|---|---|---|
| Market Cap | $2.07B | $164.85M |
| Enterprise Value | $1.90B | $87.06M |
| PE Ratio | 96.12 | 19.63 |
| PS Ratio | 6.75 | 3.60 |
| PB Ratio | 5.59 | 2.03 |
| P/TBV Ratio | 5.67 | 2.31 |
| P/FCF Ratio | 33.52 | 17.44 |
| P/OCF Ratio | 29.67 | 13.32 |
Enterprise value
| Measure | Vericel | Industry median |
|---|---|---|
| EV / Sales | 6.22 | 2.43 |
| EV / EBITDA | 61.14 | 14.69 |
| EV / EBIT | 104.46 | 18.47 |
| EV / FCF | 30.89 | 20.97 |
Income (trailing twelve months)
| Measure | Vericel | Industry median |
|---|---|---|
| Revenue | $306.30M | $57.94M |
| Gross Profit | $228.38M | $90.47M |
| Operating Income | $18.24M | -$21.44M |
| Net Income | $24.22M | -$22.46M |
| EBITDA | $31.15M | -$16.91M |
| EPS (Diluted) | $0.42 | -$0.83 |
Margins
| Measure | Vericel | Industry median |
|---|---|---|
| Gross Margin | 74.6% | 52.3% |
| Operating Margin | 5.95% | -44.5% |
| Profit Margin | 7.91% | -39.2% |
| EBITDA Margin | 10.2% | -31.3% |
| FCF Margin | 20.1% | -8.85% |
Returns
| Measure | Vericel | Industry median |
|---|---|---|
| Return on Equity (ROE) | 7.16% | -53.1% |
| Return on Assets (ROA) | 5.16% | -41.0% |
| Return on Invested Capital (ROIC) | 7.25% | -32.0% |
| Return on Capital Employed (ROCE) | 4.05% | -37.8% |
Growth
| Measure | Vericel | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 23.0% | 6.01% |
| Net Income Growth (YoY) | 240.8% | -37.7% |
| EPS Growth (YoY) | 500.0% | -29.2% |
| Revenue Growth (3Y CAGR) | 18.9% | 2.25% |
| Revenue Growth (5Y CAGR) | 17.3% | 6.42% |
| EPS Growth (5Y CAGR) | 39.8% | 3.77% |
Balance sheet
| Measure | Vericel | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $162.46M | $62.42M |
| Net Cash (Debt) | $162.46M | $15.68M |
| Net Cash Per Share | $3.17 | $0.66 |
| Equity (Book Value) | $370.04M | $48.79M |
| Book Value Per Share | $7.23 | $1.36 |
| Tangible Book Value | $364.73M | $23.06M |
| Working Capital | $212.20M | $75.77M |
Financial position
| Measure | Vericel | Industry median |
|---|---|---|
| Current Ratio | 5.04 | 3.30 |
| Quick Ratio | 4.53 | 2.39 |
| Interest Coverage | 28.49 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Vericel | Industry median |
|---|---|---|
| Operating Cash Flow | $69.67M | -$12.35M |
| Capital Expenditures | -$8.01M | -$1.06M |
| Free Cash Flow | $61.66M | -$20.28M |
| FCF Per Share | $1.20 | -$0.42 |
Efficiency
| Measure | Vericel | Industry median |
|---|---|---|
| Asset Turnover | 0.65 | 0.38 |
| Inventory Turnover | 4.43 | 2.67 |
| Revenue Per Employee | $769.61K | $398.96K |
| Profits Per Employee | $60.86K | -$703.34K |
| Employee Count | 398 | 74 |
Dividends and yields
| Measure | Vericel | Industry median |
|---|---|---|
| Earnings Yield | 1.17% | -22.7% |
| FCF Yield | 2.98% | -9.07% |
| Buyback Yield | -0.35% | -0.73% |
| Shareholder Yield | -0.35% | 0.00% |
Shares
| Measure | Vericel | Industry median |
|---|---|---|
| Shares Outstanding | 51,206,600 | 58,179,650 |
| Shares Change (YoY) | 1.27% | 11.1% |
| Shares Change (QoQ) | 0.32% | 0.54% |
| Float | 50,562,700 | 49,173,100 |
| Shares Held by Insiders | 1.26% | 11.6% |
| Shares Held by Institutions | 108.5% | 59.4% |
Scores
| Measure | Vericel | Industry median |
|---|---|---|
| Graham Number | $8.26 | $17.36 |
| Graham Upside | -79.5% | -43.6% |
| Altman Z-Score | 9.51 | -0.24 |
| Piotroski F-Score | 7 | 4 |
| Beneish M-Score | -2.53 | -2.62 |
Calculated by StockData from Vericel's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.